Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma DJ Erstad, KK Tanabe Annals of surgical oncology 26, 1474-1493, 2019 | 326 | 2019 |
Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma JSV Lally, S Ghoshal, DK DePeralta, O Moaven, L Wei, R Masia, ... Cell metabolism 29 (1), 174-182. e5, 2019 | 266 | 2019 |
Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ... Cancer cell 30 (6), 879-890, 2016 | 186 | 2016 |
Targeting the NF-κB pathway in cancer therapy DJ Erstad, JC Cusack Surgical Oncology Clinics 22 (4), 705-746, 2013 | 123 | 2013 |
Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy DJ Erstad, M Sojoodi, MS Taylor, S Ghoshal, AA Razavi, ... Disease models & mechanisms 11 (7), dmm034793, 2018 | 104 | 2018 |
Manganese-based contrast agents for magnetic resonance imaging of liver tumors: Structure–activity relationships and lead candidate evaluation J Wang, H Wang, IA Ramsay, DJ Erstad, BC Fuchs, KK Tanabe, ... Journal of medicinal chemistry 61 (19), 8811-8824, 2018 | 89 | 2018 |
Hepatocellular carcinoma: early-stage management challenges DJ Erstad, KK Tanabe Journal of Hepatocellular Carcinoma, 81-92, 2017 | 74 | 2017 |
Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy DJ Erstad, BC Fuchs, KK Tanabe Cancer 124 (15), 3084-3104, 2018 | 61 | 2018 |
Gli1 induces G2/M arrest and apoptosis in hippocampal but not tumor-derived neural stem cells KE Galvin, H Ye, DJ Erstad, R Feddersen, C Wetmore Stem cells 26 (4), 1027-1036, 2008 | 60 | 2008 |
Mutational analysis of merkel cell carcinoma DJ Erstad, JC Cusack Jr Cancers 6 (4), 2116-2136, 2014 | 53 | 2014 |
Tumor contrast enhancement and whole-body elimination of the manganese-based magnetic resonance imaging contrast agent Mn-PyC3A DJ Erstad, IA Ramsay, VC Jordan, M Sojoodi, BC Fuchs, KK Tanabe, ... Investigative radiology 54 (11), 697-703, 2019 | 51 | 2019 |
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist DJ Erstad, CT Farrar, S Ghoshal, R Masia, DS Ferreira, YCI Chen, ... Hepatology communications 2 (7), 821-835, 2018 | 47 | 2018 |
Amputation for extremity sarcoma: contemporary indications and outcomes DJ Erstad, J Ready, J Abraham, ML Ferrone, MM Bertagnolli, EH Baldini, ... Annals of surgical oncology 25, 394-403, 2018 | 47 | 2018 |
Prognostic and predictive biomarkers in colorectal cancer: implications for the clinical surgeon DJ Erstad, G Tumusiime, JC Cusack Annals of surgical oncology 22, 3433-3450, 2015 | 42 | 2015 |
Pioglitazone reduces hepatocellular carcinoma development in two rodent models of cirrhosis S Li, S Ghoshal, M Sojoodi, G Arora, R Masia, DJ Erstad, M Lanuti, ... Journal of Gastrointestinal Surgery 23 (1), 101-111, 2019 | 36 | 2019 |
Risk factors, pathogenesis, and strategies for hepatocellular carcinoma prevention: emphasis on secondary prevention and its translational challenges S Li, A Saviano, DJ Erstad, Y Hoshida, BC Fuchs, T Baumert, KK Tanabe Journal of Clinical Medicine 9 (12), 3817, 2020 | 33 | 2020 |
Fibrotic response to neoadjuvant therapy predicts survival in pancreatic cancer and is measurable with collagen-targeted molecular MRI DJ Erstad, M Sojoodi, MS Taylor, VC Jordan, CT Farrar, AL Axtell, ... Clinical Cancer Research 26 (18), 5007-5018, 2020 | 33 | 2020 |
The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction S Li, S Ghoshal, M Sojoodi, G Arora, R Masia, DJ Erstad, DS Ferriera, Y Li, ... The FASEB Journal 33 (6), 7103, 2019 | 30 | 2019 |
The DABBEC phenotyping system: towards a mechanistic understanding of CP/CPPS SA Allsop, DJ Erstad, K Brook, SF Bhai, JM Cohen, JD Dimitrakoff Nature reviews Urology 8 (2), 107-113, 2011 | 27 | 2011 |
Epigallocatechin gallate induces hepatic stellate cell senescence and attenuates development of hepatocellular carcinoma M Sojoodi, L Wei, DJ Erstad, S Yamada, T Fujii, H Hirschfield, RS Kim, ... Cancer Prevention Research 13 (6), 497-508, 2020 | 26 | 2020 |